Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT05147194
Eligibility Criteria:
Inclusion Criteria:
1. Older than 18 years of age;
2. Type 2 diabetes mellitus;
3. EGFR ≥30 to \<90 ml/min/1.73 m2;
4. Urinary albumin creatinine ratio (UACR) ≥ 30 mg/g;
Exclusion Criteria:
1. Women who are already pregnant or planning to become pregnant;
2. SBP \>180mmHg and/or DBP \>110mmHg;
3. UACR ≥ 3000 mg/g
4. Other non-diabetic renal diseases (such as polycystic kidney disease, lupus nephritis, ANCA-associated vasculitis, etc.);
5. NYHA cardiac function grade III or above
6. Those who have a history of cancer or are currently suffering from cancer;
7. Receiving immunosuppressant, cytotoxic or other immunosuppressive therapy in the first 6 months;
8. Patients with acute coronary syndrome, acute cardiac insufficiency or severe cerebrovascular disease in the previous month;
9. Patients refused to comply with the requirements of the study to complete the study;
10. In the investigator's judgment, the patient is unable to complete the study or comply with the requirements of the study (for management reasons or other reasons);
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05147194
Study Brief:
Protocol Section:
NCT05147194